Nutriband Inc (NTRB) - Net Assets
Based on the latest financial reports, Nutriband Inc (NTRB) has net assets worth $7.55 Million USD as of October 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($8.42 Million) and total liabilities ($870.21K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Nutriband Inc liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $7.55 Million |
| % of Total Assets | 89.66% |
| Annual Growth Rate | N/A |
| 5-Year Change | -9.6% |
| 10-Year Change | N/A |
| Growth Volatility | 1350.27 |
Nutriband Inc - Net Assets Trend (2016–2025)
This chart illustrates how Nutriband Inc's net assets have evolved over time, based on quarterly financial data. Also explore Nutriband Inc balance sheet assets for the complete picture of this company's asset base.
Annual Net Assets for Nutriband Inc (2016–2025)
The table below shows the annual net assets of Nutriband Inc from 2016 to 2025. For live valuation and market cap data, see NTRB company net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-01-31 | $6.43 Million | -0.14% |
| 2024-01-31 | $6.44 Million | -24.90% |
| 2023-01-31 | $8.57 Million | -27.71% |
| 2022-01-31 | $11.86 Million | +66.75% |
| 2021-01-31 | $7.11 Million | +3953.94% |
| 2020-01-31 | $175.43K | -92.70% |
| 2019-01-31 | $2.40 Million | +1878.97% |
| 2018-01-31 | $121.51K | +425.80% |
| 2017-01-31 | $23.11K | +301.47% |
| 2016-01-31 | $-11.47K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Nutriband Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 3843679600.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (January 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $11.07K | 0.17% |
| Other Comprehensive Income | $-304.00 | 0.00% |
| Other Components | $44.88 Million | 698.11% |
| Total Equity | $6.43 Million | 100.00% |
Nutriband Inc Competitors by Market Cap
The table below lists competitors of Nutriband Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Perusahaan Sadur Timah Malaysia Perstima Bhd
KLSE:5436
|
$47.00 Million |
|
Plastiblends India Limited
NSE:PLASTIBLEN
|
$47.00 Million |
|
Wolford Aktiengesellschaft
VI:WOL
|
$47.00 Million |
|
Visi Media Asia Tbk
JK:VIVA
|
$47.01 Million |
|
SolTech Energy Sweden AB
ST:SOLT
|
$46.98 Million |
|
Topmix Berhad
KLSE:0302
|
$46.97 Million |
|
DiGiSPICE Technologies Limited
NSE:DIGISPICE
|
$46.97 Million |
|
Madusari Murni Indah Tbk PT
JK:MOLI
|
$46.93 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Nutriband Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 6,438,235 to 6,429,000, a change of -9,235 (-0.1%).
- Net loss of 10,483,000 reduced equity.
- Share repurchases of 149,000 reduced equity.
- New share issuances of 8,406,591 increased equity.
- Other factors increased equity by 2,216,174.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-10.48 Million | -163.06% |
| Share Repurchases | $149.00K | -2.32% |
| Share Issuances | $8.41 Million | +130.76% |
| Other Changes | $2.22 Million | +34.47% |
| Total Change | $- | -0.14% |
Book Value vs Market Value Analysis
This analysis compares Nutriband Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 6.37x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-01-31 | $0.00 | $3.86 | x |
| 2017-01-31 | $0.00 | $3.86 | x |
| 2018-01-31 | $0.02 | $3.86 | x |
| 2019-01-31 | $0.39 | $3.86 | x |
| 2020-01-31 | $0.03 | $3.86 | x |
| 2021-01-31 | $1.06 | $3.86 | x |
| 2022-01-31 | $1.49 | $3.86 | x |
| 2023-01-31 | $1.01 | $3.86 | x |
| 2024-01-31 | $0.81 | $3.86 | x |
| 2025-01-31 | $0.61 | $3.86 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Nutriband Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -163.06%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -489.86%
- • Asset Turnover: 0.29x
- • Equity Multiplier: 1.16x
- Recent ROE (-163.06%) is above the historical average (-500.59%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 0.00% | 0.00% | 0.00x | 0.00x | $747.00 |
| 2017 | -654.55% | 0.00% | 0.00x | 1.63x | $-153.57K |
| 2018 | -2198.99% | 0.00% | 0.00x | 1.36x | $-2.68 Million |
| 2019 | -138.54% | -1358.11% | 0.09x | 1.17x | $-3.57 Million |
| 2020 | -1593.22% | -754.10% | 0.17x | 12.53x | $-2.81 Million |
| 2021 | -45.18% | -340.52% | 0.10x | 1.40x | $-3.92 Million |
| 2022 | -71.02% | -592.23% | 0.11x | 1.07x | $-9.61 Million |
| 2023 | -56.12% | -231.33% | 0.22x | 1.10x | $-5.67 Million |
| 2024 | -85.20% | -263.04% | 0.28x | 1.17x | $-6.13 Million |
| 2025 | -163.06% | -489.86% | 0.29x | 1.16x | $-11.13 Million |
Industry Comparison
This section compares Nutriband Inc's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $173,740,057
- Average return on equity (ROE) among peers: -43.94%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Nutriband Inc (NTRB) | $7.55 Million | 0.00% | 0.12x | $47.00 Million |
| Aardvark Therapeutics, Inc. Common Stock (AARD) | $-27.92 Million | 0.00% | 0.00x | $118.88 Million |
| Abcellera Biologics Inc (ABCL) | $1.06 Billion | -15.42% | 0.29x | $1.07 Billion |
| Abeona Therapeutics Inc (ABEO) | $1.69 Million | 20.23% | 0.26x | $292.09 Million |
| Acumen Pharmaceuticals Inc (ABOS) | $70.43 Million | -172.28% | 0.74x | $171.87 Million |
| Abpro Holdings, Inc. (ABP) | $-85.14 Million | 0.00% | 0.00x | $448.19K |
| Absci Corp (ABSI) | $-41.16 Million | 0.00% | 0.00x | $345.85 Million |
| Arbutus Biopharma Corp (ABUS) | $38.29 Million | -30.60% | 0.11x | $840.56 Million |
| ABVC Biopharma Inc (ABVC) | $60.67K | -43.96% | 0.04x | $26.41 Million |
| Abivax SA American Depositary Shares (ABVX) | $25.93 Million | -163.70% | 3.21x | $9.33 Billion |
| ACADIA Pharmaceuticals Inc (ACAD) | $699.13 Million | -33.65% | 0.12x | $3.74 Billion |
About Nutriband Inc
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops AVERSA b… Read more